Perfluorochemicals and Photodynamic Therapy in Mice
- 1 January 1990
- book chapter
- Published by Springer Nature
- Vol. 277, 277-282
- https://doi.org/10.1007/978-1-4684-8181-5_33
Abstract
Photodynamic therapy (PDT) is currently being evaluated for the treatment of tumours in man. It depends on the use of tumour-localising porphyrins that are activated by visible light to produce tumour destruction (Fingar et al., 1988). PDT is oxygen dependent and recent attention has focussed on strategies for improving tumour oxygenation and thereby increasing the effectiveness of PDT.Keywords
This publication has 12 references indexed in Scilit:
- Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Novel Compositions of Emulsified Perfluorochemicals for Biological UsesBiomaterials, Artificial Cells and Artificial Organs, 1988
- FluosolR Da and Oxygen as an Adjuvant to the Radiotherapeutic Management of Advanced Head/Neck CarcinomaBiomaterials, Artificial Cells and Artificial Organs, 1988
- Perfluorocarbons as oxygen-transport fluidsComparative Biochemistry and Physiology Part A: Physiology, 1987
- Meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivityBritish Journal of Cancer, 1986
- A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neckInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Increased radiosensitivity of tumors by perfluorochemicals and carbogenInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applicationsPublished by Walter de Gruyter GmbH ,1982